Apple's Legal Battle Is Wrecking Qualcomm's Licensing Business in More Ways Than One
Other upset licensees are already starting to come out of the woodwork.
How Tesla Makes Its Money: A Slicing and Dicing of Elon Musk's Fast-Growing Empire
Here's how the electric-car maker and sustainable energy company’s business breaks out by sales and relative profitability -- and where it looks to be heading.
10 Highest-Yielding Dividend Stocks Today: To Buy or Not to Buy
S&P 500 companies with yields above 5% are rare. They can also be risky. So before you add any to your portfolio, there are a few tests worth performing.
How Can I Improve My Credit Score?
Your credit score lets lenders -- and others -- gauge how responsible you are about your finances. It's well worth the effort to make yourself look as good as possible.
Investors looking for long-term growth stocks need look no further than Green Plains, Scotts Miracle-Gro, and Clean Energy Fuels.
Investing lessons from my kids just might improve your portfolio returns.
Valeant Pharmaceuticals and Gilead Sciences both look dirt cheap, but only one of these stocks is a real bargain.
Dynastic wealth can be built by buying -- and holding -- these three stocks.
CEO John Legere says that the wireless carrier "continues to perform at peak levels across the board."
The list of companies exiting the wearables market continues to grow.
Boeing stock has soared in the past year and a half, whereas Embraer stock is as beaten-down as ever. As a result, the Brazilian aerospace upstart is a better buy these days.
The casino operator's stock may be worth the gamble, but it's still a gamble.
Even after a drastic share price discount and a difficult dividend adjustment, it's still hard to recommend Frontier Communications stock as a long-term investment.
This incredible growth story is far from over.
The motorcycle and off-road vehicle company beat expectations in the face of continued industry headwinds. Here's what investors need to know.
Calthera Biosciences, Aurinia Pharmaceuticals, and Esperion Therapeutics are some of the hottest biotech stocks in 2017, and catalysts that are on deck could suggest there's more upside ahead.
The digital payments space has been hot recently, and these two players are in the best position to reap the benefits. For investors wanting a piece of that pie, which stock is the better buy?
Will Twitter prove it's making progress in turning around its declining revenue?
If you're looking for big-time yields or upside, these hidden gems are for you.
The Mac maker is still trying to find direction when it comes to automotive hardware.
Shares are trading near 52-week lows. Does that represent a buying opportunity for Stericycle stock?
Even with shares spiking so far in 2017, the streaming video giant found a way to shock Wall Street this week.
The athletic brand has partnered with rapper ASAP Rocky to lift its Lifestyle division. Will it work?